Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.111890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Tanju Kapagan und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kapagan, T., Kardes, B. C. O., Kılıc, C. E., Yontan, E., Turkmencalikoglu, M., Ozcalimli, Z., Arslansoy, B., Bulut, N., & Erdem, G. U. (2026). Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.111890
Vancouver
Kapagan T, Kardes BCO, Kılıc CE, Yontan E, Turkmencalikoglu M, Ozcalimli Z, et al. Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.111890
BibTeX
@article{Kapagan2026,
author = {Kapagan, Tanju and Kardes, Beyza Canan Ozkan and Kılıc, Cagla Ecem and Yontan, Ece and Turkmencalikoglu, Mehmet and Ozcalimli, Zozan and Arslansoy, Beyza and Bulut, Nilufer and Erdem, Gokmen Umut},
title = {Survival outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab: a comparison between ECOG performance status 0–1 and 2},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.111890}
}
EUVIMED